{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:41:35Z","timestamp":1760820095971,"version":"3.40.3"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2495,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>A new entity that comprises symptomatic worsening of an infectious or inflammatory process despite appropriate treatment was described a few years ago in human immunodeficiency virus\u2013infected patients receiving highly active antiretroviral therapy. This entity was defined as immune reconstitution syndrome, and it is believed to result from an intense inflammatory reaction in patients with an appropriately treated infection who recover immunological status. Recently, immune reconstitution syndrome has also been described in transplant recipients, although information is scarce because of its low incidence. Here we describe a new case of immune reconstitution syndrome in a liver transplant recipient after successful treatment of cryptococcal meningitis. Liver Transpl 14:1671\u20131674, 2008. \u00a9 2008 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21601","type":"journal-article","created":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T13:26:37Z","timestamp":1225286797000},"page":"1671-1674","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient"],"prefix":"10.1097","volume":"14","author":[{"given":"Gonzalo","family":"Crespo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Michelena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Navasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20250326","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1399-3062.2002.t01-1-02005.x","article-title":"Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients.","volume":"4","author":"Wu","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"R2-21-20250326","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00007890-199601150-00027","article-title":"Cryptococcal meningitis after liver transplantation.","volume":"61","author":"Jabbour","year":"1996","journal-title":"Transplantation"},{"key":"R3-21-20250326","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurininhibitor agents on mortality.","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis"},{"key":"R4-21-20250326","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease.","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Inf Dis"},{"key":"R5-21-20250326","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","article-title":"Inflammatory reactions in HIVinfected persons after initiation of highly active antiretroviral therapy.","volume":"133","author":"DeSimone","year":"2000","journal-title":"Ann Intern Med"},{"key":"R6-21-20250326","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R7-21-20250326","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1infected cohort.","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R8-21-20250326","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndromelike illness associated with Cryptococcus neoformans infection in organ transplant recipients.","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R9-21-20250326","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1399-3062.2007.00285.x","article-title":"Cytomegalovirusassociated chorioretinitis after liver transplantation: case report and review of the literature.","volume":"10","author":"Egli","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"R10-21-20250326","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-3062.2006.00194.x","article-title":"Paradoxical worsening of tuberculosis in a heartlung transplant recipient.","volume":"9","author":"Place","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"R11-21-20250326","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10096-008-0461-2","article-title":"Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipient with invasive mycoses.","volume":"6","author":"Singh","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R12-21-20250326","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/01.ASN.0000013298.11876.BF","article-title":"Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.","volume":"13","author":"Smak Gregoor","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R14-21-20250326","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(00)04055-1","article-title":"Replacement of calcineurin inhibitors with mycophenolate mofetil in livertransplant patients with renal dysfunction: a randomized controlled study.","volume":"357","author":"Schlitt","year":"2001","journal-title":"Lancet"},{"key":"R15-21-20250326","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000180530.17683.02","article-title":"Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome.","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"R16-21-20250326","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"R17-21-20250326","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jac\/dki393","article-title":"Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.","volume":"56","author":"Perkins","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R18-21-20250326","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R19-21-20250326","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/AAC.01095-06","article-title":"Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus.","volume":"51","author":"Simitsopoulou","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-21-20250326","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/14787210.4.3.469","article-title":"Evidence base for using corticosteroids to treat HIVassociated immune reconstitution syndrome.","volume":"4","author":"Lesho","year":"2006","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21601","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200811000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:02:56Z","timestamp":1743274976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200811000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21601","relation":{},"ISSN":["1527-6465"],"issn-type":[{"type":"print","value":"1527-6465"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}